This study evaluates the overall survival rate of advanced pancreatic cancer patients who pursue dose-escalated radiation therapy versus standard treatment without dose-escalated radiation therapy at 3 years.
Contact phone
(517) 364-2811
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Pancreatic
Webform